LIANHE TECHNOLOGY(002250)2025-03-12 07:20Group 1: Agricultural Protection Business - The "de-inventory" situation in the agricultural protection business is nearing completion, with signs of order volume recovery in Q4 2024 [1] - The company will continue to implement a "major customer strategy" while actively expanding new customers and products to explore new growth points [1] - The company aims to optimize production operations in the UK and establish a factory in Malaysia to enhance global competitiveness [1] Group 2: Pharmaceutical Business - The pharmaceutical business is progressing as planned, with expectations for stable development [2] - The company collaborates with leading pharmaceutical companies and focuses on expanding new customers and enhancing R&D capabilities [2] - Plans are in place to build new pharmaceutical workshops to meet future business needs [2] Group 3: New Energy Business - The new energy business is advancing with customer communication, project R&D, and quality system construction [3] - The company is entering the new energy sector with products like electrolytes, aiming for revenue breakthroughs in 2025 [3] - The competitive landscape is challenging, necessitating continuous optimization of technology, quality, and operational efficiency [3] Group 4: International Expansion and Market Dynamics - Investments in the UK and Malaysia are aimed at providing stable supply chains and enhancing service quality [4] - The impact of U.S. tariff policy changes on the company's business is limited due to the small proportion of deliveries to U.S. ports [4] - The rise of Indian CDMO companies poses competition, but their strengths in the generic drug sector do not yet extend to patented drugs [5]